International Business Development Specialist

Instytut Arcana Sp. z o.o., a Certara company, is seeking candidates for the position of International Business Development Specialist Location: Krakow, Poland About Company Arcana Institute (INAR), a healthcare-focused Market Access Consultancy company, was founded in 2002 in Cracow, Poland. Our

more

Arcana Institute, a Certara Company

Dear all, I am proud to announce that Arcana Institute (INAR), together with Analytica Laser, is now part of Certara, a global leader in model-informed drug development and regulatory science. Arcana Institute, together with Analytica Laser and other companies acquired by Certara, provides

more

HTA Master File for Central & Eastern Europe

Optimize the use of your existing data & materials on a product to build your HTA Master File for local submissions in CEE countries! The HTA Master File is a useful resource when a company already has existing material and data on

more

INAR Approach to Validation of Surrogate Endpoints

Our Findings Help Inform You on Next Step Decision-Making and Planning for Your Drug or Medical Device Our Approach Information from the validation of surrogate endpoints is used for decision-making at the company level or by HTA agencies for reimbursement. Our approach for validation of surrogate

more

Value-Based Strategy for Medical Devices

Value-Driven Health Care There is a growing recognition of value demonstration and HTA for procurement and reimbursement of medical devices in hospitals and health systems alike. In contrast to a solely price-based strategy, value-based payment strategies incorporate measures such as outcomes (including health,

more

Public Procurement of Medical Technologies in Hospitals in Poland

Expert Discussion on Public Procurement of Medical Technologies in Hospitals in Poland by Dziennik Gazeta Prawna Karolina Skóra, COO at Arcana Institute, recently participated in a panel discussion on the procurement of medical technologies for hospitals. The discussion was hosted and

more